Scribble in hematopoietic stem cell activity
造血干细胞活性的涂鸦
基本信息
- 批准号:9934991
- 负责人:
- 金额:$ 3.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AssesBlood CellsBone MarrowCell CycleCell Cycle InhibitionCell Cycle ProgressionCell Differentiation processCell PolarityCell ProliferationCell physiologyCellsChronic DiseaseComplexConfocal MicroscopyCuesCytoplasmDataDevelopmentDiseaseEuchromatinExhibitsFailureFlow CytometryGeneticGenetic DiseasesGenetic TranscriptionGoalsHematological DiseaseHematologyHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsImageIndividualInterferon Type IInterferonsInterventionLabelLarvaLeucine-Rich RepeatMalignant NeoplasmsMeasuresMediatingMesenchymal Stem CellsMolecularMolecular TargetMusNuclearNuclear TranslocationOrgan SizePathway interactionsPharmacologyPhosphorylationPhosphotransferasesPopulationProteinsRegulationResearch PersonnelResistanceResponse ElementsReverse Transcriptase Polymerase Chain ReactionRoleSTAT1 geneSTAT2 geneSignal PathwaySignal TransductionStem cell transplantStem cellsStressStructureTestingTherapeuticTranslatingTransplantationVirus DiseasesWorkcancer geneticscell behaviorcell typechemotherapycytokinecytopeniaexhaustionhematopoietic stem cell fatehematopoietic stem cell quiescencehematopoietic stem cell self-renewalimprovedin vivoinsightleukemiamembermutantnovelpolarized cellprogenitorprogramspublic health relevancereconstitutionresponseself-renewaltranscriptome
项目摘要
DESCRIPTION (provided by applicant): The potential of hematopoietic stem cells (HSC) to reconstitute the hematopoietic system has allowed for the development of transplantation approaches to treat cancer and hematologic diseases. Cell cycle status of HSC defines their ability to engraft in conditioned recipients and has been hypothesized as a mechanism for chemotherapy-resistant HSC-derived leukemias. HSC are highly quiescent cells with the ability to rapidly enter the cell cycle and differentiate through changes in their polarity and disposition
of intracellular molecular fate determinants in response to microenvironment (ME) cues. In bone marrow (BM) hematopoiesis, interferons type I (IFN-I), a ME cytokine produced in response to viral infection, have been shown to be a crucial positive regulator to induce proliferation of otherwise quiescent hematopoietic stem cells (qHSC). Our preliminary data indicate that Scribble deficient HSC are insensitive to IFN-I and retain cellular quiescence in vivo. Our preliminary data also show that the Hippo effector Yap1, which also regulates stem cell proliferation in response to ME signals, is polarized and co-localizes in the cytoplasm with Scribble in wild type HSC. Deficiency of Scribble in HSC results in Yap1 translocation to nuclear euchromatin suggesting a novel Scribble-mediated mechanism used to protect qHSC from potential damage associated with cellular activation. Our data suggests that Scribble distinctly regulates HSC cell cycle progression in a context-dependent manner. We believe that ME IFN-I induced HSC proliferative signaling program depends on Scribble and that Scribble deficiency abrogates HSC polarization leading to reduced quiescence and subsequent HSC exhaustion through activation of downstream Hippo effectors. To gain insight into these ME dependent signaling pathways that control HSC activity, we plan to analyze both IFN-I response signaling pathways and Hippo signaling in Scribble proficient and deficient HSC. We will utilize flow cytometry and confocal microscopy to define a role for Scribble in mediating such signals. Functionally, we will test the reconstitution abilities of wild type and Scribble structure-functio mutants in Scribble deficient HSC through serial transplantations. Dissecting the microenvironment dependent Scribble-mediated molecular mechanisms that govern HSC quiescence will help refine the significance and therapeutic potential of naturally occurring IFN molecules and identify novel targets for intervention in HSC disease.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Jordan Althoff其他文献
Targeting Mitochondrial Calcium Uptake to Eradicate Venetoclax-Resistant Acute Myeloid Leukemia Stem Cells
- DOI:
10.1182/blood-2023-188285 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Anagha Inguva Sheth;Krysta Engel;Hunter Tolison;Mark Jordan Althoff;Anna Krug;Maria L Amaya;Shanshan Pei;Tracy Young;Sweta B Patel;Mohd Minhajuddin;Regan Miller;Ian Shelton;Ana Vujovic;Courtney L Jones;Austin E Gillen;Monica Ransom;Sarah Staggs;Clayton Smith;Daniel A. Pollyea;Brett M Stevens - 通讯作者:
Brett M Stevens
Mark Jordan Althoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Jordan Althoff', 18)}}的其他基金
Understanding the unique dependency for MCL1 in Ven/Aza resistant AML
了解 MCL1 在 Ven/Aza 耐药 AML 中的独特依赖性
- 批准号:
10535785 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
Understanding the unique dependency for MCL1 in Ven/Aza resistant AML
了解 MCL1 在 Ven/Aza 耐药 AML 中的独特依赖性
- 批准号:
10671482 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
相似海外基金
Designing and fabricating artificial blood cells for global shortages
设计和制造人造血细胞应对全球短缺
- 批准号:
DE240100236 - 财政年份:2024
- 资助金额:
$ 3.75万 - 项目类别:
Discovery Early Career Researcher Award
The Use of Blood Cells and Optical Cerebral Complex IV Redox States in a Porcine Model of CO Poisoning with Evaluation of Mitochondrial Therapy
血细胞和光脑复合物 IV 氧化还原态在猪 CO 中毒模型中的应用及线粒体治疗的评价
- 批准号:
10734741 - 财政年份:2023
- 资助金额:
$ 3.75万 - 项目类别:
Elucidation of white blood cells propulsion mechanism under a cytokine concentration gradient assuming concentration Marangoni effect.
假设浓度马兰戈尼效应,阐明细胞因子浓度梯度下白细胞的推进机制。
- 批准号:
23KJ1753 - 财政年份:2023
- 资助金额:
$ 3.75万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mechanisms of oxygen off-loading from red blood cells in murine models of human disease
人类疾病小鼠模型中红细胞的氧卸载机制
- 批准号:
10343967 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
Study of somatic mutations in normal blood cells using whole-genome sequencing
使用全基因组测序研究正常血细胞的体细胞突变
- 批准号:
22K20840 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
EAGER: Compact Field Portable Biophotonics Instrument for Real-Time Automated Analysis and Identification of Blood Cells Impact Impacted by COVID-19
EAGER:紧凑型现场便携式生物光子学仪器,用于实时自动分析和识别受 COVID-19 影响的血细胞
- 批准号:
2141473 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
Standard Grant
Mechanisms of oxygen off-loading from red blood cells in murine models of human disease
人类疾病小鼠模型中红细胞的氧卸载机制
- 批准号:
10548180 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
Bioenergetics of red blood cells regulated by hydrogen sulfide
硫化氢调节红细胞的生物能
- 批准号:
RGPIN-2017-04392 - 财政年份:2022
- 资助金额:
$ 3.75万 - 项目类别:
Discovery Grants Program - Individual
Mechanical Characterization of Human Red Blood Cells
人红细胞的机械特性
- 批准号:
562095-2021 - 财政年份:2021
- 资助金额:
$ 3.75万 - 项目类别:
University Undergraduate Student Research Awards
Bioenergetics of red blood cells regulated by hydrogen sulfide
硫化氢调节红细胞的生物能
- 批准号:
RGPIN-2017-04392 - 财政年份:2021
- 资助金额:
$ 3.75万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




